Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells
Kayla M. Borland, Safnas F. AbdulSalam, Morwena J. Solivio, Matthew P. Burke, Patrick R. Wolfkiel, Sean M. Lawson, Courtney A. Stockman, Joel M. Andersen, Skyler Smith, Julia N. Tolstolutskaya, Purujit N. Gurjar, Aron P. Bercz, Edward J. Merino, Vladislav A. Litosh
Dive into the research topics of 'Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells'. Together they form a unique fingerprint.